Nykode Therapeutics AS (VACBF)
OTCMKTS
· Delayed Price · Currency is USD
0.2046
-0.0245 (-10.69%)
At close: Jun 3, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of $57.20 million as of June 18, 2025. Its market cap has decreased by -88.60% in one year.
Market Cap
57.20M
Enterprise Value
-51.59M
Revenue
8.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 604.82M to 57.20M, a decrease of -90.54%. That is a compound annual growth rate of -35.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 57.20M | -34.59% |
| Dec 30, 2024 | 87.46M | -87.31% |
| Dec 29, 2023 | 689.14M | -18.07% |
| Dec 30, 2022 | 841.13M | -68.30% |
| Dec 30, 2021 | 2.65B | 6.21% |
| Dec 30, 2020 | 2.50B | 313.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Elite Pharmaceuticals | 827.80M |
| Veradigm | 747.25M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 437.04M |
| American Oncology Network | 408.69M |
| Glass House Brands | 398.13M |